Peginterferon α-2b (PegIFNα2b), a long-acting IFN formed by the combination of polyethylene glycol (PEG) and recombinant IFN-α-2b, has already been tested to treat GIST. The gene discussed is IFNA2; the disease is gastrointestinal stromal tumor.